Answers are grounded in this paper and cite their sources.
The Diagnostic Root Audit (DRA) is an evidence-based, cross-functional protocol for identifying and addressing revenue leakage in B2B industrial enterprises. It examines the commercial commitment and its operational and cash consequences across the journey from initial inquiry and quotation to delivery and final collection. The paper presents a five-phase diagnostic method: historical transaction reconstruction; touch-time and wait-time analysis; margin and discount decomposition; stage-gate governance verification; and development of a diagnostic scorecard and corrective blueprint. By reconciling CRM and quotation histories with financial records, contracts, delivery logs, cost and time data, and collection records, DRA helps distinguish recognized revenue, expected pipeline value, and cash actually collected. The framework is designed to help leaders identify operational sources of margin erosion, slow cash conversion, weak buyer qualification, uncontrolled discounting, scope expansion, and mismatches between selling and delivery capacity. It supports evidence-based prioritization of corrective actions before increasing demand-generation spending, applying further discounts, or changing personnel. Within the Vandabon methodology, DRA provides a diagnostic baseline for Value Positioning & Architecture (VPA) and structured pipeline, outcome, and loss data for Systemic Strategy-to-Implementation Orchestration (SSIO). DRA is a management diagnostic framework; its findings depend on the availability and quality of organizational data and should be validated against operational evidence.
No takes yet. Share an insight, caveat, or question.
Ahmad Rahmatkhah (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: